Polycab India F&O ban from Dec 30: Stock falls 5%; Key dates, trading rules, and what happens next LiveMint · Markets 19m ago
Syndax Reports Phase 2 Setback For Axatilimab In Idiopathic Pulmonary Fibrosis NASDAQ · Markets 21m ago
Visa To Take Steps Pursuant To PBOC's Regulations To Begin Operating Domestically In China NASDAQ · Markets 27m ago